Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction

Liver International

Volumn 30, Issue 8, 2010, Pages 1143-1151

  Goel, Amit ^a   Yadav, Santosh ^a   Saraswat, Vivek ^a   Srivastava, Arti ^a   Thomas, M Albert ^b   Pandey, Chandra M ^a   Rathore, Ramkishore ^c   Gupta, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

1H magnetic resonance spectroscopy; Extrahepatic portal vein obstruction; Hyperammonaemia; Minimal hepatic encephalopathy; MR imaging

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; SERUM ALBUMIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN EDEMA; BRAIN WATER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CRITICAL FLICKER FUSION; DIFFUSION TENSOR IMAGING; EXTRAHEPATIC PORTAL VENOUS OBSTRUCTION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; MALE; MINIMAL HEPATIC ENCEPHALOPATHY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PROTON NUCLEAR MAGNETIC RESONANCE; VEIN OCCLUSION;

ADOLESCENT; ADULT; AMMONIA; BRAIN; BRAIN EDEMA; CONSTRICTION, PATHOLOGIC; FEMALE; FLICKER FUSION; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PORTAL VEIN;

EID: 79951599502     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02289.x     Document Type: Article

References (23)

1. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
2. Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549-59.
3. Sharma P, Sharma BC, Puri V, et al. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008; 103: 1406-12.
4. Minguez B, Garcia-Pagan JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006; 43: 707-14.
5. Rovira A, Grive E, Pedraza S, et al. Magnetization transfer ratio values and proton MR spectroscopy of normalappearing cerebral white matter in patients with liver cirrhosis. Am J Neuroradiol 2001; 22: 1137-42.
6. Miese F, Kircheis G, Wittsack HJ, et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006; 27: 1019-26.
7. Kreis R, Ross BD, Farrow NA, et al. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27.
8. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
9. Haussinger D, Kircheis G, Fischer R, et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000; 32: 1035-8.
10. Rose C, Butterworth RF, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-4.
11. Laubenberger J, Haussinger D, Bayer S, et al. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 1610-6.
12. Atterbury CE, MaddreyWC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy: a controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398-406.
13. Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-5.
14. Kircheis G, Wettstein M, Timmermann L, et al. Critical icker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.
15. Hasan KM, Gupta RK, Santos RM, et al. Diffusion tensor fractional anisotropy of normal appearing seven segments of corpus callosum in healthy adult and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 2005; 21: 735-43.
16. Verma A, Saraswat VA, Radha Krishna Y, et al. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 2008; 28: 1095-103.
17. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LC Model. NMR Biomed 2001; 14: 260-4.
18. Sharma P, Sharma BC, Puri V, et al. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007; 47: 10-1.
19. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991; 179: 551-5.
20. Geissler A, Lock G, Frund R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25: 48-54.
21. Klein J, Gonzalez R, Koppen A, et al. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 1993; 22: 293-300.
22. Galea E, Estrada C. Quabain-sensitive choline transport system in capillaries isolated from bovine brain. J Neurochem 1992; 59: 936-41.
23. Rao VL, Therrien G, Butterworth RF. Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy. Metab Brain Dis 1994; 9: 401-7.